緑内障治療の世界市場

【英語タイトル】Global Glaucoma Treatment Market

Future Market Insightsが出版した調査資料(FMI22MA033)・商品コード:FMI22MA033
・発行会社(調査会社):Future Market Insights
・発行日:2022年3月
・ページ数:331
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single Price(1名様閲覧用)USD5,000 ⇒換算¥740,000見積依頼/購入/質問フォーム
Site Licence(同一拠点内共有可)USD7,500 ⇒換算¥1,110,000見積依頼/購入/質問フォーム
Enterprisewide(複数拠点内共有可)USD10,000 ⇒換算¥1,480,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、世界の緑内障治療市場について調査し、エグゼクティブサマリー、市場概要、市場リスク・動向分析、市場背景、主要成功要因、需要分析・予測、価格分析・予測、疾患種類別(開放隅角緑内障、閉塞隅角緑内障、その他)分析、薬剤クラス別(プロスタグランジン類似体、ベータ遮断薬、アドレナリン作動薬、炭酸脱水酵素阻害剤、その他)分析、流通チャネル別(病院薬局、小売薬局、オンライン薬局)分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを整理しました。
・エグゼクティブサマリー
・市場概要
・市場リスク・動向分析
・市場背景
・主要成功要因
・需要分析・予測
・価格分析・予測
・世界の緑内障治療市場規模:疾患種類別(開放隅角緑内障、閉塞隅角緑内障、その他)
・世界の緑内障治療市場規模:薬剤クラス別(プロスタグランジン類似体、ベータ遮断薬、アドレナリン作動薬、炭酸脱水酵素阻害剤、その他)
・世界の緑内障治療市場規模:流通チャネル別(病院薬局、小売薬局、オンライン薬局)
・世界の緑内障治療市場規模:地域別
・市場構造分析
・競争分析
・仮定
・調査手法
【レポートの概要】

A recent market study published by Future Market Insights on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022–2032. The study offers a comprehensive assessment of the more important market dynamics.

After conducting thorough research on the historical and current growth parameters of the Glaucoma Treatment Market, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

The Glaucoma Treatment Market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.

By Disease Type
Open Angle Glaucoma
Angle Closure Glaucoma
Other

By Drug Class
Prostaglandin Analog
Beta Blockers
Adrenergic Agonist
Carbonic Anhydrase Inhibitors
Others

By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Region
North America
Latin America
Europe
Asia Pacific
Middle East and Africa (MEA)

Report Chapters

Chapter 01 – Executive Summary

The executive summary of the Glaucoma Treatment Market includes the market proprietary wheel of fortune, demand-side and supply-side trends, opportunity assessment, and recommendations on the Glaucoma Treatment Market.

 Chapter 02 – Market Overview

Readers can find the detailed segmentation and definition of the Glaucoma Treatment Market in this chapter, which will help them understand basic information about the Glaucoma Treatment Market. This section also highlights the inclusions and exclusions, which help the reader, understand the scope of the Glaucoma Treatment Market report.

 Chapter 03 – Market Background

The associated industry assessment of the Glaucoma Treatment Market is carried out in this section. The macroeconomic factors affecting the growth of the Glaucoma Treatment Market are provided in this section and the impact of these macroeconomic indicators on the Glaucoma Treatment Market is analyzed. The processing overview and technological advancements in the Glaucoma Treatment Market are also provided.

Chapter 04 – Glaucoma Treatment Market Value Chain

Profit margins at each level of the Glaucoma Treatment Market are analyzed and readers can find detailed information on top importers and exporters as well as the value chain of the Glaucoma Treatment Market. 

 Chapter 05 – Market Dynamics

The drivers and restraints impacting the growth of the Glaucoma Treatment Market are explained in this chapter. Opportunities and ongoing trends in the Glaucoma Treatment Market are also comprehensively discussed. 

Chapter 06 – Glaucoma Treatment Market – Pricing Analysis

This chapter includes global as well as regional pricing analysis by product type. The pricing influencing factors are also explained in this chapter. The readers can understand the manufacturer level, distributor level as well as retail level pricing analysis for 2022 and 2032. 

Chapter 07 – Glaucoma Treatment Market Demand Analysis and Forecast 2022-2029  

This chapter includes a detailed analysis of the historical Glaucoma Treatment Market (2014-2021), along with an opportunity analysis for the forecast period (2022-2032). Readers can also find the absolute $ opportunity for the current year (2022) and incremental opportunity for the forecast period (2022-2032).

Chapter 8 – Global Glaucoma Treatment Market Analysis (2014-2021) & Opportunity Assessment (2022-2032), By Disease Type

Based on the Disease Type, the Glaucoma Treatment Market is segmented into Open Angle, Angle Closure, Others. In this chapter, readers can find information about key trends and developments in the Glaucoma Treatment Market and market attractive analysis based on the Disease Type.

Chapter 9 – Global Glaucoma Treatment Market Analysis (2014-2021) & Opportunity Assessment (2022-2032), By Drug Class

Based on the Drug Class, the Glaucoma Treatment Market is segmented into Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others. In this chapter, readers can find information about key trends and developments in the Glaucoma Treatment Market and market attractive analysis based on the Drug Class.

Chapter 10 – Global Glaucoma Treatment Market Analysis (2014-2021) & Opportunity Assessment (2022-2032), By Distribution Channel

Based on the Distribution Channel, the Glaucoma Treatment Market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy. In this chapter, readers can find information about key trends and developments in the Glaucoma Treatment Market and market attractive analysis based on Distribution Channel.

Chapter 11 – Global Glaucoma Treatment Market Analysis (2014-2021) & Opportunity Assessment (2022-2032), By Region

This chapter explains how the Glaucoma Treatment Market will grow across various geographic regions, such as North America, Latin America, Western Europe, Eastern Europe, Southeast Asia & Pacific, China, India, Japan and the Middle East & Africa (MEA).

Chapter 12 – North America Glaucoma Treatment Market Analysis 2014-2021 & Opportunity Assessment 2022-2032

This chapter includes detailed analysis of the growth of the North America Glaucoma Treatment Market along with the country-wise assessment including the U.S. and Canada. Readers can also find regional trends and market growth based on Disease Type, Drug Class, Distribution Channel, and country of Glaucoma Treatment in North America.

Chapter 13 – Latin America Glaucoma Treatment Market Analysis 2014-2021 & Opportunity Assessment 2022-2032

Readers can find detailed information about factors such as, pricing analysis, and regional trends that are impacting the growth of the Latin America Glaucoma Treatment Market. This chapter also includes the growth prospects of the Glaucoma Treatment Market in leading LATAM countries such as Brazil, Mexico, and rest of the Latin America region.

Chapter 14 – Eastern Europe Glaucoma Treatment Market Analysis 2014-2021 & Forecast 2022-2032

This chapter includes a detailed analysis of the growth of the Eastern Europe Glaucoma Treatment Market, along with a country-wise assessment that includes Poland, Czech Republic and Rest of Eastern Europe. Readers can also find the pricing analysis, regional trends, and market growth based on countries in Eastern Europe.

Chapter 15 – Western Europe Glaucoma Treatment Market Analysis 2014-2021 & Forecast 2022-2032

This chapter includes a detailed analysis of the growth of the Western Europe Glaucoma Treatment Market, along with a country-wise assessment that includes the U.K., France, Germany and Rest of Western Europe. Readers can also find the pricing analysis, regional trends, and market growth based on countries in Western Europe.

Chapter 16 – APEJ Glaucoma Treatment Market Analysis 2014-2021 & Opportunity Assessment 2022-2032

Readers can find thorough information about the growth parameters of the APEJ Glaucoma Treatment Market during the period 2022-2032.

Chapter 17 – Japan Glaucoma Treatment Market Analysis 2014-2021 & Opportunity Assessment 2022-2032

Readers can find important factors that can make a huge impact on the growth of the Glaucoma Treatment Market in Japan based on the market segmentation, during the forecast period. This chapter provides the overview of drivers, restraints, and trends in the Japan Glaucoma Treatment Market.

Chapter 18 – MEA Glaucoma Treatment Market Analysis 2014-2021 & Opportunity Assessment 2022-2032

This chapter provides information on how the Glaucoma Treatment Market will grow in the major countries in MEA region, such as GCC Countries, South Africa and Rest of MEA during the period 2022-2029.

Chapter 19 – Competition Landscape, Company Share and Company Profiles

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Glaucoma Treatment Market along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments.

Chapter 20 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 21 – Research Methodology

This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the Glaucoma Treatment Market.

【レポートの目次】

1. Executive Summary

    1.1. Global Market Outlook 

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Fact.MR Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy 

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment 

    3.1. Risk Assessment 

        3.1.1. COVID-19 Crisis and Impact on Glaucoma Treatment Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis 

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background 

    4.1. Glaucoma Treatment Market, by Key Countries

    4.2. Glaucoma Treatment Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast 

        4.3.1. Demand in Optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario 

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors – Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Glaucoma Treatment Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Glaucoma Treatment Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors 

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking 

6. Global Glaucoma Treatment Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Glaucoma Treatment Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032, By Disease Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Disease Type, 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Type, 2022-2032

        8.3.1. Open Angle Glaucoma

        8.3.2. Angle Closure Glaucoma

        8.3.3. Others

    8.4. Market Attractiveness Analysis By Disease Type

9. Global Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032, By Drug Class

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2015-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2022-2032

        9.3.1. Prostaglandin Analogs

        9.3.2. Beta Blockers

        9.3.3. Adrenergic Agonists

        9.3.4. Carbonic Anhydrase Inhibitors

        9.3.5. Others

    9.4. Market Attractiveness Analysis By Drug Class

10. Global Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032, By Distribution Channel

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Disease Type, 2015-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022-2032

        10.3.1. Hospital Pharmacy

        10.3.2. Retail Pharmacy

        10.3.3. Online Pharmacy

    10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. Asia Pacific 

        11.3.5. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. U.S.

            12.4.1.2. Canada

            12.4.1.3. Rest of North America

        12.4.2. By Disease Type

        12.4.3. By Distribution Channel

        12.4.4. By Drug Class

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Disease Type

        12.5.3. By Distribution Channel

        12.5.4. By Drug Class

13. Latin America Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. Brazil

            13.4.1.2. Mexico

            13.4.1.3. Rest of Latin America

        13.4.2. By Disease Type

        13.4.3. By Distribution Channel

        13.4.4. By Drug Class

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Disease Type

        13.5.3. By Distribution Channel

        13.5.4. By Drug Class

14. Europe Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. Germany

            14.4.1.2. France

            14.4.1.3. U.K.

            14.4.1.4. Italy

            14.4.1.5. Benelux

            14.4.1.6. Nordic Countries

            14.4.1.7. Rest of Europe

        14.4.2. By Disease Type

        14.4.3. By Distribution Channel

        14.4.4. By Drug Class

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Disease Type

        14.5.3. By Distribution Channel

        14.5.4. By Drug Class

15. Asia Pacific Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. China

            15.4.1.2. Japan

            15.4.1.3. South Korea

            15.4.1.4. Rest of Asia Pacific

        15.4.2. By Disease Type

        15.4.3. By Distribution Channel

        15.4.4. By Drug Class

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Disease Type

        15.5.3. By Distribution Channel

        15.5.4. By Drug Class

16. Middle East and Africa Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. GCC Countries

            16.4.1.2. South Africa

            16.4.1.3. Turkey

            16.4.1.4. Rest of Middle East and Africa

        16.4.2. By Disease Type

        16.4.3. By Distribution Channel

        16.4.4. By Drug Class

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Disease Type

        16.5.3. By Distribution Channel

        16.5.4. By Drug Class

17. Key Countries Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032

    17.1. Introduction

        17.1.1. Market Value Proportion Analysis, By Key Countries

        17.1.2. Global Vs. Country Growth Comparison

    17.2. US Glaucoma Treatment Market Analysis

        17.2.1. Value Proportion Analysis by Market Taxonomy

        17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.2.2.1. By Disease Type

            17.2.2.2. By Distribution Channel

            17.2.2.3. By Drug Class

    17.3. Canada Glaucoma Treatment Market Analysis

        17.3.1. Value Proportion Analysis by Market Taxonomy

        17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.3.2.1. By Disease Type

            17.3.2.2. By Distribution Channel

            17.3.2.3. By Drug Class

    17.4. Mexico Glaucoma Treatment Market Analysis

        17.4.1. Value Proportion Analysis by Market Taxonomy

        17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.4.2.1. By Disease Type

            17.4.2.2. By Distribution Channel

            17.4.2.3. By Drug Class

    17.5. Brazil Glaucoma Treatment Market Analysis

        17.5.1. Value Proportion Analysis by Market Taxonomy

        17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.5.2.1. By Disease Type

            17.5.2.2. By Distribution Channel

            17.5.2.3. By Drug Class

    17.6. Germany Glaucoma Treatment Market Analysis

        17.6.1. Value Proportion Analysis by Market Taxonomy

        17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.6.2.1. By Disease Type

            17.6.2.2. By Distribution Channel

            17.6.2.3. By Drug Class

    17.7. France Glaucoma Treatment Market Analysis

        17.7.1. Value Proportion Analysis by Market Taxonomy

        17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.7.2.1. By Disease Type

            17.7.2.2. By Distribution Channel

            17.7.2.3. By Drug Class

    17.8. Italy Glaucoma Treatment Market Analysis

        17.8.1. Value Proportion Analysis by Market Taxonomy

        17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.8.2.1. By Disease Type

            17.8.2.2. By Distribution Channel

            17.8.2.3. By Drug Class

    17.9. BENELUX Glaucoma Treatment Market Analysis

        17.9.1. Value Proportion Analysis by Market Taxonomy

        17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.9.2.1. By Disease Type

            17.9.2.2. By Distribution Channel

            17.9.2.3. By Drug Class

    17.10. UK Glaucoma Treatment Market Analysis

        17.10.1. Value Proportion Analysis by Market Taxonomy

        17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.10.2.1. By Disease Type

            17.10.2.2. By Distribution Channel

            17.10.2.3. By Drug Class

    17.11. Nordic Countries Glaucoma Treatment Market Analysis

        17.11.1. Value Proportion Analysis by Market Taxonomy

        17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.11.2.1. By Disease Type

            17.11.2.2. By Distribution Channel

            17.11.2.3. By Drug Class

    17.12. China Glaucoma Treatment Market Analysis

        17.12.1. Value Proportion Analysis by Market Taxonomy

        17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.12.2.1. By Disease Type

            17.12.2.2. By Distribution Channel

            17.12.2.3. By Drug Class

    17.13. Japan Glaucoma Treatment Market Analysis

        17.13.1. Value Proportion Analysis by Market Taxonomy

        17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.13.2.1. By Disease Type

            17.13.2.2. By Distribution Channel

            17.13.2.3. By Drug Class

    17.14. South Korea Glaucoma Treatment Market Analysis

        17.14.1. Value Proportion Analysis by Market Taxonomy

        17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.14.2.1. By Disease Type

            17.14.2.2. By Distribution Channel

            17.14.2.3. By Drug Class

    17.15. GCC Countries Glaucoma Treatment Market Analysis

        17.15.1. Value Proportion Analysis by Market Taxonomy

        17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.15.2.1. By Disease Type

            17.15.2.2. By Distribution Channel

            17.15.2.3. By Drug Class

    17.16. South Africa Glaucoma Treatment Market Analysis

        17.16.1. Value Proportion Analysis by Market Taxonomy

        17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.16.2.1. By Disease Type

            17.16.2.2. By Distribution Channel

            17.16.2.3. By Drug Class

    17.17. Turkey Glaucoma Treatment Market Analysis

        17.17.1. Value Proportion Analysis by Market Taxonomy

        17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.17.2.1. By Disease Type

            17.17.2.2. By Distribution Channel

            17.17.2.3. By Drug Class

        17.17.3. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies 

    18.2. Market Concentration

    18.3. Market Share Analysis of Top Players

    18.4. Market Presence Analysis

        18.4.1. By Regional footprint of Players

        18.4.2. Product footprint by Players

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive 

        19.3.1. AERIE Pharmaceuticals, Inc.

            19.3.1.1. Overview

            19.3.1.2. Product Portfolio

            19.3.1.3. Sales Footprint

            19.3.1.4. Strategy Overview

        19.3.2. Cipla Inc.

            19.3.2.1. Overview

            19.3.2.2. Product Portfolio

            19.3.2.3. Sales Footprint

            19.3.2.4. Strategy Overview

        19.3.3. Akorn Operating Company LLC

            19.3.3.1. Overview

            19.3.3.2. Product Portfolio

            19.3.3.3. Sales Footprint

            19.3.3.4. Strategy Overview

        19.3.4. AbbVie

            19.3.4.1. Overview

            19.3.4.2. Product Portfolio

            19.3.4.3. Sales Footprint

            19.3.4.4. Strategy Overview

        19.3.5. Bausch & Lomb Incorporated

            19.3.5.1. Overview

            19.3.5.2. Product Portfolio

            19.3.5.3. Sales Footprint

            19.3.5.4. Strategy Overview

        19.3.6. Inotek Pharmaceuticals

            19.3.6.1. Overview

            19.3.6.2. Product Portfolio

            19.3.6.3. Sales Footprint

            19.3.6.4. Strategy Overview

        19.3.7. Merck & Co., Inc.

            19.3.7.1. Overview

            19.3.7.2. Product Portfolio

            19.3.7.3. Sales Footprint

            19.3.7.4. Strategy Overview

        19.3.8. Novartis AG

            19.3.8.1. Overview

            19.3.8.2. Product Portfolio

            19.3.8.3. Sales Footprint

            19.3.8.4. Strategy Overview

        19.3.9. Pfizer Inc.

            19.3.9.1. Overview

            19.3.9.2. Product Portfolio

            19.3.9.3. Sales Footprint

            19.3.9.4. Strategy Overview

        19.3.10. Santen Pharmaceutical Co., Ltd.

            19.3.10.1. Overview

            19.3.10.2. Product Portfolio

            19.3.10.3. Sales Footprint

            19.3.10.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

Table 1: Global Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2015 – 2021

Table 2: Global Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2022 – 2032

Table 3: Global Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2015 – 2021

Table 4: Global Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2022 – 2032

Table 5: Global Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2015 – 2021

Table 6: Global Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2022 – 2032

Table 7: Global Glaucoma Treatment Market, By Region, 2015 – 2021

Table 8: Global Glaucoma Treatment Market, By Region, 2022 – 2032

Table 9: North America Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2015 – 2021

Table 10: North America Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2022 – 2032

Table 11: North America Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2015 – 2021

Table 12: North America Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2022 – 2032

Table 13: North America Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2015 – 2021

Table 14: North America Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2022 – 2032

Table 15: North America Glaucoma Treatment Market, By Country, 2015 – 2021

Table 16: North America Glaucoma Treatment Market, By Country, 2022 – 2032

Table 17: Latin America Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2015 – 2021

Table 18: Latin America Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2022 – 2032

Table 19: Latin America Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2015 – 2021

Table 20: Latin America Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2022 – 2032

Table 21: Latin America Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2015 – 2021

Table 22: Latin America Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2022 – 2032

Table 23: Latin America Glaucoma Treatment Market, By Country, 2015 – 2021

Table 24: Latin America Glaucoma Treatment Market, By Country, 2022 – 2032

Table 25: Europe Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2015 – 2021

Table 26: Europe Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2022 – 2032

Table 27: Europe Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2015 – 2021

Table 28: Europe Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2022 – 2032

Table 29: Europe Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2015 – 2021

Table 30: Europe Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2022 – 2032

Table 31: Europe Glaucoma Treatment Market, By Country, 2015 – 2021

Table 32: Europe Glaucoma Treatment Market, By Country, 2022 – 2032

Table 33: Asia Pacific Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2015 – 2021

Table 34: Asia Pacific Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2022 – 2032

Table 35: Asia Pacific Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2015 – 2021

Table 36: Asia Pacific Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2022 – 2032

Table 37: Asia Pacific Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2015 – 2021

Table 38: Asia Pacific Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2022 – 2032

Table 39: Asia Pacific Glaucoma Treatment Market, By Country, 2015 – 2021

Table 40: Asia Pacific Glaucoma Treatment Market, By Country, 2022 – 2032

Table 41: MEA Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2015 – 2021

Table 42: MEA Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2022 – 2032

Table 43: MEA Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2015 – 2021

Table 44: MEA Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2022 – 2032

Table 45: MEA Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2015 – 2021

Table 46: MEA Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2022 – 2032

Table 47: MEA Glaucoma Treatment Market, By Country, 2015 – 2021

Table 48: MEA Glaucoma Treatment Market, By Country, 2022 – 2032

Table 49: Global Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2015 - 2021

Table 50: Global Glaucoma Treatment Market Incremental $ Opportunity, By Distribution Channel, 2022 – 2032

Table 51: Global Glaucoma Treatment Market Incremental $ Opportunity, By Drug Class, 2015 - 2021

Table 52: Global Glaucoma Treatment Market Incremental $ Opportunity, By Region, 2022 – 2032

Table 53: North America Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2015 - 2021

Table 54: North America Glaucoma Treatment Market Incremental $ Opportunity, By Distribution Channel, 2022 – 2032

Table 55: North America Glaucoma Treatment Market Incremental $ Opportunity, By Drug Class, 2015 – 2021

Table 56: North America Glaucoma Treatment Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 57: Latin America Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2015 - 2021

Table 58: Latin America Glaucoma Treatment Market Incremental $ Opportunity, By Distribution Channel, 2022 – 2032

Table 59: Latin America Glaucoma Treatment Market Incremental $ Opportunity, By Drug Class, 2015 - 2021

Table 60: Latin America Glaucoma Treatment Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 61: Europe Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2015 - 2021

Table 62: Europe Glaucoma Treatment Market Incremental $ Opportunity, By Distribution Channel, 2022 – 2032

Table 63: Europe Glaucoma Treatment Market Incremental $ Opportunity, By Drug Class, 2015 - 2021

Table 64: Europe Glaucoma Treatment Market Incremental $ Opportunity, By Country, 2022 - 2032

Table 65: Asia Pacific Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2015 - 2021

Table 66: Asia Pacific Glaucoma Treatment Market Incremental $ Opportunity, By Distribution Channel, 2022 – 2032

Table 67: Asia Pacific Glaucoma Treatment Market Incremental $ Opportunity, By Distribution Channel, 2015 - 2021

Table 68: Asia Pacific Glaucoma Treatment Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 69: MEA Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2015 - 2021

Table 70: MEA Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2022 – 2032

Table 71: MEA Glaucoma Treatment Market Incremental $ Opportunity, By Drug Class, 2015 - 2021

Table 72: MEA Glaucoma Treatment Market Incremental $ Opportunity, By Country, 2022 - 2032

Figure 1: Global Glaucoma Treatment Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 2: Global Glaucoma Treatment Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Glaucoma Treatment Market Share, By Disease Type, 2022 & 2032

Figure 4: Global Glaucoma Treatment Market Y-o-Y Growth Projections, By Disease Type – 2022-2032

Figure 5: Global Glaucoma Treatment Market Attractiveness Index, By Disease Type – 2022-2032

Figure 6: Global Glaucoma Treatment Market Share, By Distribution Channel, 2022 & 2032

Figure 7: Global Glaucoma Treatment Market Y-o-Y Growth Projections, By Distribution Channel – 2022-2032

Figure 8: Global Glaucoma Treatment Market Attractiveness Index, By Distribution Channel – 2022-2032

Figure 9: Global Glaucoma Treatment Market Share, By Drug Class, 2022 & 2032

Figure 10: Global Glaucoma Treatment Market Y-o-Y Growth Projections, By Drug Class – 2022-2032

Figure 11: Global Glaucoma Treatment Market Attractiveness Index, By Drug Class – 2022-2032

Figure 12: Global Glaucoma Treatment Market Share, By Region, 2022 & 2032

Figure 13: Global Glaucoma Treatment Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 14: Global Glaucoma Treatment Market Attractiveness Index, By Region – 2022-2032

Figure 15: North America Glaucoma Treatment Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 16: North America Glaucoma Treatment Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 17: North America Glaucoma Treatment Market Share, By Disease Type, 2022 & 2032

Figure 18: North America Glaucoma Treatment Market Y-o-Y Growth Projections, By Disease Type – 2022-2032

Figure 19: North America Glaucoma Treatment Market Attractiveness Index, By Disease Type – 2022-2032

Figure 20: North America Glaucoma Treatment Market Share, By Distribution Channel, 2022 & 2032

Figure 21: North America Glaucoma Treatment Market Y-o-Y Growth Projections, By Distribution Channel – 2022-2032

Figure 22: North America Glaucoma Treatment Market Attractiveness Index, By Distribution Channel – 2022-2032

Figure 23: North America Glaucoma Treatment Market Share, By Drug Class, 2022 & 2032

Figure 24: North America Glaucoma Treatment Market Y-o-Y Growth Projections, By Drug Class – 2022-2032

Figure 25: North America Glaucoma Treatment Market Attractiveness Index, By Drug Class – 2022-2032

Figure 26: North America Glaucoma Treatment Market Share, By Country, 2022 & 2032

Figure 27: North America Glaucoma Treatment Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 28: North America Glaucoma Treatment Market Attractiveness Index, By Country – 2022-2032

Figure 29: Latin America Glaucoma Treatment Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 30: Latin America Glaucoma Treatment Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 31: Latin America Glaucoma Treatment Market Share, By Disease Type, 2022 & 2032

Figure 32: Latin America Glaucoma Treatment Market Y-o-Y Growth Projections, By Disease Type – 2022-2032

Figure 33: Latin America Glaucoma Treatment Market Attractiveness Index, By Disease Type – 2022-2032

Figure 34: Latin America Glaucoma Treatment Market Share, By Distribution Channel, 2022 & 2032

Figure 35: Latin America Glaucoma Treatment Market Y-o-Y Growth Projections, By Distribution Channel – 2022-2032

Figure 36: Latin America Glaucoma Treatment Market Attractiveness Index, By Distribution Channel – 2022-2032

Figure 37: Latin America Glaucoma Treatment Market Share, By Drug Class, 2022 & 2032

Figure 38: Latin America Glaucoma Treatment Market Y-o-Y Growth Projections, By Drug Class – 2022-2032

Figure 39: Latin America Glaucoma Treatment Market Attractiveness Index, By Drug Class – 2022-2032

Figure 40: Latin America Glaucoma Treatment Market Share, By Country, 2022 & 2032

Figure 41: Latin America Glaucoma Treatment Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 42: Latin America Glaucoma Treatment Market Attractiveness Index, By Country – 2022-2032

Figure 43: Europe Glaucoma Treatment Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 44: Europe Glaucoma Treatment Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 45: Europe Glaucoma Treatment Market Share, By Disease Type, 2022 & 2032

Figure 46: Europe Glaucoma Treatment Market Y-o-Y Growth Projections, By Disease Type – 2022-2032

Figure 47: Europe Glaucoma Treatment Market Attractiveness Index, By Disease Type – 2022-2032

Figure 48: Europe Glaucoma Treatment Market Share, By Distribution Channel, 2022 & 2032

Figure 49: Europe Glaucoma Treatment Market Y-o-Y Growth Projections, By Distribution Channel – 2022-2032

Figure 50: Europe Glaucoma Treatment Market Attractiveness Index, By Distribution Channel – 2022-2032

Figure 51: Europe Glaucoma Treatment Market Share, By Drug Class, 2022 & 2032

Figure 52: Europe Glaucoma Treatment Market Y-o-Y Growth Projections, By Drug Class – 2022-2032

Figure 53: Europe Glaucoma Treatment Market Attractiveness Index, By Drug Class – 2022-2032

Figure 54: Europe Glaucoma Treatment Market Share, By Country, 2022 & 2032

Figure 55: Europe Glaucoma Treatment Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 56: Europe Glaucoma Treatment Market Attractiveness Index, By Country – 2022-2032

Figure 57: MEA Glaucoma Treatment Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 58: MEA Glaucoma Treatment Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 59: MEA Glaucoma Treatment Market Share, By Disease Type, 2022 & 2032

Figure 60: MEA Glaucoma Treatment Market Y-o-Y Growth Projections, By Disease Type – 2022-2032

Figure 61: MEA Glaucoma Treatment Market Attractiveness Index, By Disease Type – 2022-2032

Figure 62: MEA Glaucoma Treatment Market Share, By Distribution Channel, 2022 & 2032

Figure 63: MEA Glaucoma Treatment Market Y-o-Y Growth Projections, By Distribution Channel – 2022-2032

Figure 64: MEA Glaucoma Treatment Market Attractiveness Index, By Distribution Channel – 2022-2032

Figure 65: MEA Glaucoma Treatment Market Share, By Drug Class, 2022 & 2032

Figure 66: MEA Glaucoma Treatment Market Y-o-Y Growth Projections, By Drug Class – 2022-2032

Figure 67: MEA Glaucoma Treatment Market Attractiveness Index, By Drug Class – 2022-2032

Figure 68: MEA Glaucoma Treatment Market Share, By Country, 2022 & 2032

Figure 69: MEA Glaucoma Treatment Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 70: MEA Glaucoma Treatment Market Attractiveness Index, By Country – 2022-2032

Figure 71: Asia Pacific Glaucoma Treatment Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 72: Asia Pacific Glaucoma Treatment Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 73: Asia Pacific Glaucoma Treatment Market Share, By Disease Type, 2022 & 2032

Figure 74: Asia Pacific Glaucoma Treatment Market Y-o-Y Growth Projections, By Disease Type – 2022-2032

Figure 75: Asia Pacific Glaucoma Treatment Market Attractiveness Index, By Disease Type – 2022-2032

Figure 76: Asia Pacific Glaucoma Treatment Market Share, By Distribution Channel, 2022 & 2032

Figure 77: Asia Pacific Glaucoma Treatment Market Y-o-Y Growth Projections, By Distribution Channel – 2022-2032

Figure 78: Asia Pacific Glaucoma Treatment Market Attractiveness Index, By Distribution Channel – 2022-2032

Figure 79: Asia Pacific Glaucoma Treatment Market Share, By Drug Class, 2022 & 2032

Figure 80: Asia Pacific Glaucoma Treatment Market Y-o-Y Growth Projections, By Drug Class – 2022-2032

Figure 81: Asia Pacific Glaucoma Treatment Market Attractiveness Index, By Drug Class – 2022-2032

Figure 82: Asia Pacific Glaucoma Treatment Market Share, By Country, 2022 & 2032

Figure 83: Asia Pacific Glaucoma Treatment Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 84: Asia Pacific Glaucoma Treatment Market Attractiveness Index, By Country – 2022-2032

Figure 85: US Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 86: US Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 87: US Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 88: US Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 89: Canada Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 90: Canada Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 91: Canada Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 92: Canada Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 93: Brazil Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 94: Brazil Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 95: Brazil Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 96: Brazil Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 97: Mexico Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 98: Mexico Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 99: Mexico Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 100: Mexico Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 101: Germany Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 102: Germany Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 103: Germany Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 104: Germany Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 105: U.K. Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 106: U.K. Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 107: U.K. Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 108: U.K. Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 109: France Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 110: France Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 111: France Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 112: France Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 113: Italy Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 114: Italy Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 115: Italy Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 116: Italy Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 117: BENELUX Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 118: BENELUX Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 119: BENELUX Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 120: BENELUX Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 121: Nordic Countries Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 122: Nordic Countries Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 123: Nordic Countries Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 124: Nordic Countries Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 125: China Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 126: China Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 127: China Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 128: China Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 129: Japan Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 130: Japan Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 131: Japan Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 132: Japan Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 133: South Korea Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 134: South Korea Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 135: South Korea Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 136: South Korea Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 137: GCC Countries Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 138: GCC Countries Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 139: GCC Countries Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 140: GCC Countries Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 141: South Africa Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 142: South Africa Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 143: South Africa Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 144: South Africa Glaucoma Treatment Market Share, By Drug Class, 2021

Figure 145: Turkey Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 146: Turkey Glaucoma Treatment Market Share, By Disease Type, 2021

Figure 147: Turkey Glaucoma Treatment Market Share, By Distribution Channel, 2021

Figure 148: Turkey Glaucoma Treatment Market Share, By Drug Class, 2021

★調査レポート[緑内障治療の世界市場] (コード:FMI22MA033)販売に関する免責事項を必ずご確認ください。
★調査レポート[緑内障治療の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆